These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [On the cholinolytic activity of pramiverine]. Enenkel HJ; Müller-Calgan H; Schorscher E Arzneimittelforschung; 1976 Apr; 26(4b):690-6. PubMed ID: 821493 [TBL] [Abstract][Full Text] [Related]
43. Design, synthesis, and pharmacological activities of 2-substituted 4-phenylquinolines as potential antidepressant drugs. Alhaider AA; Abdelkader MA; Lien EJ J Med Chem; 1985 Oct; 28(10):1394-8. PubMed ID: 4045918 [TBL] [Abstract][Full Text] [Related]
44. Pharmacological studies on the stereoselective antihistaminic and anticholinergic properties of L(S)- and D(R)-3-ethylamino-1-phenylpyrrolidine. Gerald MC; Sethi OP; Muhi-Eldeen Z; Mahishi N; Witiak DT Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):78-87. PubMed ID: 4398412 [No Abstract] [Full Text] [Related]
45. The significance of differences in the potency of enantiomers of anti-acetylcholine drugs. Brimblecombe RW; Green DM; Inch TD; Thompson PB J Pharm Pharmacol; 1971 Oct; 23(10):745-57. PubMed ID: 4399909 [No Abstract] [Full Text] [Related]
46. Synthesis and antispasmodic activity evaluation of bis-(papaverine) analogues. Kaur J; Ghosh NN; Chandra R Chem Pharm Bull (Tokyo); 2004 Mar; 52(3):316-21. PubMed ID: 14993754 [TBL] [Abstract][Full Text] [Related]
47. [Synthesis and antidepressive effects of diaryl-4,6-amino-3-pyridazine analogs of minaprine]. Coudert P; Rubat C; Couquelet JM; Bastide J Farmaco Sci; 1988 Oct; 43(10):793-800. PubMed ID: 3240830 [TBL] [Abstract][Full Text] [Related]
48. New classes of antimuscarinic agents endowed with selective antispasmodic properties. 1-Arylsulfonyl pyrrolidin-2-ones and 2-thiones, 1-arylsulfonyl piperidin-2-ones and 2-thiones and 1-arylsulfonyl hexahydro-2H-azepin-2-one. Toja E; Parini C; Bonetti C; Hunt P; Fortin M; Barzaghi F; Cesana R; Maggioni A; Nencioni A; Galliani G Arzneimittelforschung; 1994 Apr; 44(4):501-9. PubMed ID: 8011004 [TBL] [Abstract][Full Text] [Related]
49. 1-Aryl-2-(aminomethyl)cyclopropanecarboxylic acid derivatives. A new series of potential antidepressants. Bonnaud B; Cousse H; Mouzin G; Briley M; Stenger A; Fauran F; Couzinier JP J Med Chem; 1987 Feb; 30(2):318-25. PubMed ID: 3806614 [TBL] [Abstract][Full Text] [Related]
50. Rociverine, a new antispasmodic agent with balanced neurotropic and myotropic activity. Toson G; Schiantarelli P; Murmann W Arzneimittelforschung; 1978; 28(7):1130-42. PubMed ID: 582702 [TBL] [Abstract][Full Text] [Related]
51. Structure-activity relations for anticholinergic 2(1-aryl(or cyclohexyl)-1-hydroxy-1-phenyl)methyl-1,3-dioxolans. Brimblecombe RW; Inch TD; Wetherell J; Williams N J Pharm Pharmacol; 1971 Sep; 23(9):649-61. PubMed ID: 4398243 [No Abstract] [Full Text] [Related]
52. Stereochemical requirements for central and peripheral muscarinic and antimuscarinic activity of some acetylenic compounds related to oxotremorine. Dahlbom R; Jenden DJ; Resul B; Ringdahl B Br J Pharmacol; 1982 Jun; 76(2):299-304. PubMed ID: 7093587 [TBL] [Abstract][Full Text] [Related]
53. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers. Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246 [TBL] [Abstract][Full Text] [Related]
54. Analogues of oxybutynin. Synthesis and antimuscarinic and bladder activity of some substituted 7-amino-1-hydroxy-5-heptyn-2-ones and related compounds. Carter JP; Noronha-Blob L; Audia VH; Dupont AC; McPherson DW; Natalie KJ; Rzeszotarski WJ; Spagnuolo CJ; Waid PP; Kaiser C J Med Chem; 1991 Oct; 34(10):3065-74. PubMed ID: 1920357 [TBL] [Abstract][Full Text] [Related]
55. Adamantanealkanamines as potential antidepressant and anti-Parkinson agents. Chakrabarti JK; Foulis MJ; Hotten TM; Szinai SS; Todd A J Med Chem; 1974 Jun; 17(6):602-9. PubMed ID: 4829941 [No Abstract] [Full Text] [Related]
56. 2-Aryloxymethyl-2,3,5,6-tetrahydro-1,4-oxazines, a new class of antidepressants. Greenwood DT; Mallion KB; Todd AH; Turner RW J Med Chem; 1975 Jun; 18(6):573-7. PubMed ID: 1151970 [TBL] [Abstract][Full Text] [Related]
57. Oxybutynin--a musculotropic antispasmodic drug with moderate anticholinergic action. Lish PM; Labudde JA; Peters EL; Robbins SI Arch Int Pharmacodyn Ther; 1965 Aug; 156(2):467-88. PubMed ID: 4380481 [No Abstract] [Full Text] [Related]
58. Synthesis and cardioselective beta-adrenergic antagonist activity of quinolyloxypropanolamines. Vo D; Wolowyk MW; Knaus EE Drug Des Discov; 1992; 9(1):69-78. PubMed ID: 1360842 [TBL] [Abstract][Full Text] [Related]
59. [Cyclohexylphenoxymorpholines with antidepressive activity]. Carissimi M; Picciòla G; Ravenna F; Gentili P; Carenini G Farmaco Sci; 1980 Jun; 35(6):504-26. PubMed ID: 7192648 [TBL] [Abstract][Full Text] [Related]
60. Some pharmacological properties of a novel series of 2-substituted 2-phenylcyclohexyl N,N-diethylaminoethyl ethers I. Thompson EB; Huang LB; Lu MC Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):241-64. PubMed ID: 7367747 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]